Zenotech Laboratories Ltd

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with the Board of Directors approving the results and the independent auditor's review report attached.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd has approved unaudited financial results for the quarter and half year ended September 30, 2026, with the standalone balance sheet as at September 30, 2026, attached.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd has scheduled a board meeting on October 28, 2026, to consider and approve unaudited standalone financial results for the quarter and half year ended September 30, 2026.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd has filed a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd has announced the closure of its trading window from October 1, 2026, till 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd's 37th Annual General Meeting (AGM) was held on September 25, 2026, with all resolutions approved with the requisite majority. The meeting was conducted via video conferencing, and the voting results were disclosed. The company's financial statements for the financial year ended March 31, 2026, were adopted, and the appointment of Mr. Jignesh Anantray Goradia was approved. Additionally, a material related party transaction with Sun Pharmaceutical Industries Limited was approved.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd held its 37th Annual General Meeting on September 25, 2026, approving resolutions including re-appointment of a director and related party transactions. The company reported a 1.5% increase in revenue for FY 2025-26, but a loss after tax.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd has published newspaper advertisements for its 37th Annual General Meeting and E-Voting.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd has announced its 37th Annual General Meeting (AGM) to be held on September 25, 2026, along with the Annual Report for FY 2025-26. The meeting will consider the adoption of audited standalone financial statements, re-appointment of a director, and approval of a related party transaction with Sun Pharmaceutical Industries Limited.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd has released its Annual Report 2025-26 and announced the 37th Annual General Meeting, scheduled for September 25, 2026. The report includes the company's financial statements, auditor's report, and management discussion and analysis. The meeting will consider the adoption of audited financial statements, re-appointment of a director, and approval of a related party transaction.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd has published a newspaper advertisement for its 37th Annual General Meeting to be held on September 25, 2026, through video conferencing.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd has announced the 37th Annual General Meeting (AGM) to be held on September 25, 2026, through video conferencing. The meeting will be held at 10:30 a.m. IST, and the company has set a cut-off date of September 18, 2026, for shareholders to register their email addresses, update their mobile numbers, and cast their votes through e-voting.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd has published its unaudited financial results for the quarter ended June 30, 2026, showing a net loss of ₹45.55 lakhs and a total income from operations of ₹1,104.79 lakhs.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026, with revenue from operations at Rs 959.64 lakhs and total income at Rs 1,104.79 lakhs. The company has also approved convening its 37th Annual General Meeting on September 25, 2026.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd submitted unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 959.64 lakhs and total income at Rs. 1,104.79 lakhs. The company also announced the convening of its 37th Annual General Meeting on September 25, 2026.